Titlebook: Renal Anemia; Conflicts and Contro Onyekachi Ifudu (Associate Professor of Medicine, Book 2002 Springer Science+Business Media Dordrecht 2

落后的煤渣

書(shū)目名稱Renal Anemia影響因子(影響力)




書(shū)目名稱Renal Anemia影響因子(影響力)學(xué)科排名




書(shū)目名稱Renal Anemia網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Renal Anemia網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Renal Anemia被引頻次




書(shū)目名稱Renal Anemia被引頻次學(xué)科排名




書(shū)目名稱Renal Anemia年度引用




書(shū)目名稱Renal Anemia年度引用學(xué)科排名




書(shū)目名稱Renal Anemia讀者反饋




書(shū)目名稱Renal Anemia讀者反饋學(xué)科排名

俗艷

Insul島

ellagic-acid

Clinton D. Brown,Zhong H. Zhao,Lorraine L. Thomas,Robert deGroof,Eli A. Friedman

etiquette

Onyekachi Ifudu (Associate Professor of Medicine,

小教堂

Is long-term intravenous iron therapy risky?,Cs also contributed to iron overloading in the past and was associated with iron deposits in liver reticuloendothelial and parenchymal cells. However, iron overloading was not associated with functional changes in the liver (i.e., increases in liver function tests or cirrhosis) unless PRBC transfusions resulted in viral hepatitis [1].

包租車船

bronchiole

Normalizing hematocrit in renal failure: dangerous or desirable?, or fully corrected is arguably the most debated and controversial issue in this aspect of patient management. Why is this so? If one examines the scientific evidence relating to this topic, one can find both circumstantial evidence, and also evidence from intervention clinical trials [4–11].

Suggestions

山頂可休息

Epilogue,traordinary impact of treatment with erythropoietin in functionally anephric peritoneal dialysis and hemodialysis patients, Ifudu convened diverse professionals with shared interest in the uremic patient and concentrated their attention on the remarkable positive change in rehabilitation potential imparted by recombinant erythropoietin.